Viewing nowHirus Tablet (Vildagliptin)
Vildagliptin 50mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

MFDS item code 202200168 · Approved 2022.01.10 · Insurance code 644309670
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used alone or in combination with diet and exercise for the treatment of patients with type 2 diabetes to improve blood sugar control.
This medicine may be administered as monotherapy, or in combination with metformin in patients with no prior experience of antidiabetic drug treatment, at a dose of 50mg once daily in the morning or 100mg daily, divided into 50mg twice daily in the morning and evening. When this medicine is administered in combination with metformin or a thiazolidinedione in patients whose blood glucose is not adequately controlled with metformin or thiazolidinedione monotherapy, the recommended dose is 100mg daily, divided into 50mg twice daily in the morning and evening. When this medicine is administered in combination with a sulfonylurea in patients whose blood glucose is not adequately controlled with sulfonylurea monotherapy, the recommended dose is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. When this medicine is administered as triple therapy in combination with a sulfonylurea and metformin in patients whose blood glucose is not adequately controlled with combination therapy of a sulfonylurea and metformin, the recommended dose is 100mg daily, divided into 50mg twice daily in the morning and evening. When this medicine is administered in combination with insulin (insulin alone or with metformin) in patients whose blood glucose is not adequately controlled with insulin therapy, the recommended dose is 100mg daily, divided into 50mg twice daily in the morning and evening. This medicine may be taken with or without food, and doses exceeding 100mg daily are not recommended. When this medicine is administered with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it as soon as you remember, and take the next dose at the usual time. If you remember close to the time of the next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment. Patients with renal impairment Patients with mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. Patients with moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See section 2) under “3. General Precautions” in Precautions for Use.
This medication should not be used by patients who are allergic to the active ingredient or any other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Since this medication contains lactose, it should not be used in patients with lactose intolerance or genetic lactose-related diseases. During treatment with this medication, liver dysfunction may rarely occur; therefore, regular liver function tests should be conducted before and during use. If liver enzyme levels rise more than three times the normal level or if symptoms of jaundice appear, discontinue use of this medication. Use is not recommended in patients with severe heart failure, as it may worsen heart failure symptoms, and caution is advised. This medication carries a risk of acute pancreatitis; therefore, if symptoms of pancreatitis occur, discontinue use immediately and consult a healthcare professional. When used in combination with sulfonylureas or other medications that may cause hypoglycemia, the risk of hypoglycemia may increase, and dosage adjustments may be needed. If symptoms such as dizziness occur while taking this medication, avoid driving or operating machinery. If severe joint pain or skin abnormalities such as blisters or ulcers occur, notify a healthcare professional immediately and discontinue this medication. It is safe not to use this medication in pregnant or breastfeeding women, and it is not recommended for children and adolescents under 18 years of age. There is no specific antidote for overdose; therefore, symptomatic supportive treatment should be initiated, and this medication cannot be removed by hemodialysis. Keep out of reach of children and avoid transferring to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its effectiveness.
Round tablet that is white to pale yellow in color
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVildagliptin 50mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Ahn-Guk New Pharm Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.
Vildagliptin 50mg
Tablet · Prescription medication
Pharmgen Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.